2/ The main pillars of mucosal immunity in the respiratory system are:
– Innate immunity. This ancient part includes the physical barrier: mucus production and continuous flow upwards, driven by ciliary epithelial cells. There are also phagocytes ("eating cells") and…
3/ …other cellular components that produce signaling molecules, set traps, etc.

– Adaptive immunity
---> B & plasma cells that release antibodies into the airways through the single cell layer called the epithelium.
4/ These antibodies (Ab) are called secretory immunoglobulins (SIgA mainly), bind pathogens and can be similarly specific as their systemic counterparts. They can even cross-link pathogens to mucus, inactivating them.
5/ Their special part is a secretory component, very rich in added sugar chains (glycans). This "band" is missing from circulating IgA, and there is a very good reason why mucosal surfaces utilize this subtype. See my mini thread on the war of glycans here https://twitter.com/gerdosi/status/1289674834608377856?s=20
6/ B cells develop immune memory, meaning that upon reinfection with the same or very similar pathogen specific Ab are released.
---> Antigen presenting, mainly dendritic cells.

Next
---> T-cells. These can be categorized into 2 main types:
7/ CD4+ "helper" cells in specific forms against various pathogens. They help innate cells as well as B cells to fight invaders in an optimal way. CD8+ cells which are killer lymphocytes but specialized to hunt down our own infected cells.
8/ Both play fundamental roles in mucosal immunity.

A substantial impairment in any of the above components leads to profoundly higher susceptibility to severe infections. Yes, even mucus and its flow is a very important player.
9/ OK, now let's talk a bit about systemic Ab, which tend to grab all the attention. Are these integral parts of mucosal immunity? Well, not really. They mostly come into the picture when ALL other barriers mentioned above fail.
10/ That is exactly why disease severity, more precisely systemic dissemination of the virus, is linked to higher serum Ab levels. Those people who fight off the infection with primary defenses produce lower and more quickly waning systemic Ab levels. That's perfectly normal.
11/ One last question to mucosal immunity in the airways: Does it have its own memory? You bet it does. Not only B/plasma cells can enter this memory phase, but both CD4+ and CD8+ T-cell types as well. Yes, they keep sitting in the airway walls for decades, waiting for…
12/ …the same or a fairly similar pathogen to attack. This is a lasting type of immune memory.
Now, back to the press release at hand. The major claim is that SYSTEMIC Ab quickly wane, and that it raises serious doubts not only about lasting, but also herd immunity.
13/ How quickly this decay happens depends on the methods of determination, e.g. Ab against which antigens are used, the method sensitivity itself, e.g. quick test vs. fancy lab techniques, etc. In line with this, another study just 2 weeks ago…
14/ …concluded that this decay is not so rapid at all. https://uahs.arizona.edu/news/uarizona-health-sciences-study-shows-sars-cov-2-antibodies-provide-lasting-immunity
What is more, memory B cells persist even if antibodies disappear! See https://twitter.com/gerdosi/status/1298378005061021696?s=20

The authors of the new Imperial College study are cautious and fair enough with their interpretations:
15/ "Our study shows that over time there is a reduction in the proportion of people testing positive for antibodies. "It remains unclear what level of immunity antibodies provide, or for how long this immunity lasts." they continue.
16/ Now, let's see how clueless or malevolent commenters in mainstream media interpret the very same study:
"We can see the antibodies and we can see them declining and we know antibodies on their own are quite protective." says Prof Wendy Barclay to the BBC.
17/ If you have read the above, you already know that these Ab are only protective against severe systemic disease. They cannot prevent upper respiratory symptoms or even a mild pneumonia, not to mention becoming infectious. The article also makes more bold claims…
18/ "The researchers say their findings do not scupper hopes of a vaccine, which may prove more effective than a real infection." To prevent respiratory symptoms & infectiousness, an animal model study showed that 8-times normal (!) level of systemic Ab is necessary to develop.
19/ I don't think that the first wave of vaccines even aims for that, especially not in the most vulnerable (whom they typically exclude from trials), and especially not in a lasting way.
Prof Jonathan Heeney, a virologist at the University of Cambridge, goes even further…
You can follow @gerdosi.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled: